Inactive Instrument

Highlights Nivalis Therapeutics Inc Nasdaq

Equities

US65481J1097

Highlights

Unlock all the news: Be the first to know and act before the market!

Vertex Pharmaceuticals Incorporated completed the acquisition of Alpine Immune Sciences, Inc. from a group of shareholders.	05-19	CI
Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone	05-10	MT
Alpine Immune Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09	CI
MOVES -Lazard hires veteran healthcare dealmaker Colocci as vice chairman	05-09	RE
Vertex Pharmaceuticals 1Q Sales Up 13% on Cystic Fibrosis Drug	05-06	DJ
Health Care Slips on Risk Bias -- Health Care Roundup	04-11	DJ
Global markets live: Airbus, UBS, KKR, Meta Platforms, Tesla...	04-11
Sector Update: Health Care Stocks Steady Pre-Bell Thursday	04-11	MT
Sector Update: Health Care	04-11	MT
Top Premarket Gainers	04-11	MT
Vertex Pharmaceuticals' $4.9 Billion Deal for Alpine Shows Lead-Candidate's Potential, Analysts Say	04-11	MT
Alpine Immune Sciences Shares Rally After Vertex Agrees to Acquire Co.	04-10	DJ
Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion -- Update	04-10	DJ
Vera Therapeutics Shares Rise 9.9% After Alpine Acquisition	04-10	DJ
Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion	04-10	MT
Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion	04-10	DJ
Vertex Pharmaceuticals to buy Alpine Immune Sciences for $4.9 bln	04-10	RE
Alpine Immune Sciences Shares Updated Clinical Data from Povetacicept in IgA Nephropathy	04-10	CI
Vertex Enters Deal to Buy Alpine Immune Sciences For $65/Share, or About $4.9 Billion Cash; Alpine Due Off After-Hours Halt at 4:30 pm ET	04-10	MT
Vertex to acquire Alpine Immune Sciences for $4.9 bln	04-10	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Nivalis Therapeutics Inc Nasdaq

Equities

US65481J1097

Highlights

Filters